Royal Bank of Canada’s Global X Scientific Beta Europe ETF SCID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-239
Closed -$5K 7224
2020
Q2
$5K Buy
239
+99
+71% +$2.08K ﹤0.01% 6078
2020
Q1
$3K Buy
+140
New +$3.32K ﹤0.01% 6251

Royal Bank of Canada's SCID Position: Q3 2020 in Review

Royal Bank of Canada sold out of Global X Scientific Beta Europe ETF (SCID) in Q3 2020, closing a stake of 239 shares — an estimated $5K sold.

Royal Bank of Canada first reported a position in SCID in Q1 2020 and held it in 2 quarters. The position peaked at $5K in Q2 2020. 0 funds tracked by Wall St. Rank hold SCID as of Q3 2020.

  • Royal Bank of Canada reported no remaining Global X Scientific Beta Europe ETF position as of Q3 2020 after selling out during the quarter.
  • Royal Bank of Canada sold 239 Global X Scientific Beta Europe ETF shares in Q3 2020, an estimated $5K.
  • Royal Bank of Canada first reported a position in Global X Scientific Beta Europe ETF in Q1 2020 and held it in 2 quarters.
  • Royal Bank of Canada's Global X Scientific Beta Europe ETF position peaked at $5K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Global X Scientific Beta Europe ETF as of Q3 2020.

Based on Royal Bank of Canada's 13F filing for Q3 2020, filed 16 Nov 2020.